JNJ

224.93

-1.11%↓

UNH

368.46

-0.15%↓

TMO

464.97

-0.92%↓

ISRG

451.72

-1.28%↓

ABT

88.25

-1.41%↓

JNJ

224.93

-1.11%↓

UNH

368.46

-0.15%↓

TMO

464.97

-0.92%↓

ISRG

451.72

-1.28%↓

ABT

88.25

-1.41%↓

JNJ

224.93

-1.11%↓

UNH

368.46

-0.15%↓

TMO

464.97

-0.92%↓

ISRG

451.72

-1.28%↓

ABT

88.25

-1.41%↓

JNJ

224.93

-1.11%↓

UNH

368.46

-0.15%↓

TMO

464.97

-0.92%↓

ISRG

451.72

-1.28%↓

ABT

88.25

-1.41%↓

JNJ

224.93

-1.11%↓

UNH

368.46

-0.15%↓

TMO

464.97

-0.92%↓

ISRG

451.72

-1.28%↓

ABT

88.25

-1.41%↓

Search

Simulations Plus Inc

Abierto

SectorSanidad

14.83 4.66

Resumen

Variación precio

24h

Actual

Mínimo

14.73

Máximo

14.9

Métricas clave

By Trading Economics

Ingresos

3.9M

4.5M

Ventas

5.9M

24M

BPA

0.35

Rentabilidad por dividendo

0.48

Margen de beneficios

18.669

Empleados

212

EBITDA

4.9M

7.2M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+7.31% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.36%

Próximas Ganancias

13 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

44M

295M

Apertura anterior

10.17

Cierre anterior

14.83

Noticias sobre sentimiento de mercado

By Acuity

24%

76%

42 / 347 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

3 may 2026, 23:47 UTC

Ganancias

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 may 2026, 22:35 UTC

Ganancias

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 may 2026, 23:39 UTC

Charlas de Mercado

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 may 2026, 23:34 UTC

Charlas de Mercado

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 may 2026, 23:32 UTC

Ganancias

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 may 2026, 23:30 UTC

Charlas de Mercado

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 may 2026, 23:20 UTC

Charlas de Mercado

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 may 2026, 23:16 UTC

Adquisiciones, fusiones, absorciones

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 may 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 may 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 may 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 may 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 may 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 may 2026, 22:45 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

3 may 2026, 22:45 UTC

Charlas de Mercado

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 may 2026, 22:20 UTC

Ganancias

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 may 2026, 22:08 UTC

Ganancias

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 may 2026, 22:05 UTC

Ganancias

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 may 2026, 22:05 UTC

Ganancias

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 may 2026, 22:05 UTC

Ganancias

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 may 2026, 22:04 UTC

Ganancias

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 may 2026, 22:03 UTC

Ganancias

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 may 2026, 22:03 UTC

Ganancias

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 may 2026, 22:02 UTC

Ganancias

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 may 2026, 22:02 UTC

Ganancias

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 may 2026, 22:02 UTC

Ganancias

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 may 2026, 22:01 UTC

Ganancias

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 may 2026, 22:01 UTC

Ganancias

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 may 2026, 22:01 UTC

Ganancias

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 may 2026, 15:06 UTC

Ganancias

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

7.31% repunte

Estimación a 12 Meses

Media 16 USD  7.31%

Máximo 16 USD

Mínimo 16 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

2

Comprar

1

Mantener

0

Vender

Sentimiento

By Acuity

42 / 347 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat